Results 81 to 90 of about 8,702 (224)

No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy [PDF]

open access: yes, 2018
We report on four patients with narcolepsy with cataplexy (NC), who were treated with high-dose intravenous immunoglobulins (IVIg). Although in some patients transient effects were seen of both objective (multiple sleep latency test and maintenance of ...
Bassetti, C.   +3 more
core  

Orexin system and pathogenesis of sleep-wake cycle disturbances in narcolepsy

open access: yesБюллетень сибирской медицины, 2018
Sleep is the one of the most important vital functions of the body. The study of the primary mechanisms that result in disturbance of the sleep-wake cycle is a priority of modern medical science.
Yu. V. Gavrilov   +2 more
doaj   +1 more source

Microbial‐Immune Interplay in CNS Autoimmune Diseases: Lessons from Animal Models and Clinical Studies

open access: yesEuropean Journal of Immunology, Volume 56, Issue 2, February 2026.
Mechanism of action of the intestinal microbiota on CNS autoimmune diseases. Environmental factors shape gut microbiota composition; dysbiosis alters microbial metabolites and antigenic signals. These modulate innate and adaptive immunity, affect barrier integrity, and influence CNS‐resident cells such as microglia and astrocytes, contributing to ...
Matteo Ceccon, Francesca Ronchi
wiley   +1 more source

Brazilian guidelines for the diagnosis of narcolepsy [PDF]

open access: yes, 2010
Este artigo relata as conclusões da reunião de consenso com médicos especialistas sobre diagnóstico de narcolepsia baseada na revisão dos artigos sobre narcolepsia listados no Medline entre 1980 e 2010.
ALVES, Rosana Cardoso   +28 more
core   +3 more sources

Persistence of poor sleep predicts the severity of the clinical condition after 6months of standard treatment in patients with eating disorders [PDF]

open access: yes, 2015
Clinical evidence suggests that eating disorder (ED) patients experience poor sleep even if they rarely complain of it. However, direct empirical evidence supporting this relationship is still sparse.
Battagliese, Gemma   +3 more
core   +1 more source

Narcolepsy: a case report and review of literature

open access: yesNeurologijos seminarai, 2019
Narcolepsy is one of the central hypersomnias associated with a tetrad of symptoms: excessive daytime sleepiness, cataplexy, sleep paralysis, and hypnagogic hallucinations.
E. Baltakytė   +2 more
doaj   +1 more source

Narcolepsy Associated With Streptococcal Infection: A Case Report and Literature Review

open access: yesClinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Streptococcal infection–induced narcolepsy is a rare neurological disorder that may be accompanied by severe psychiatric symptoms and social dysfunction. In this case, delayed diagnosis and treatment were followed by progressive symptom worsening, including marked cognitive decline.
Zhenzhen Zhu   +5 more
wiley   +1 more source

GHB’s Path to Legitimacy: An Administrative and Legislative History of Xyrem [PDF]

open access: yes, 2012
This paper traces the path of a chemical compound (gamma-hydroxybutyrate, or GHB) from its status as an abused street drug to that of a legitimate, life-altering prescription treatment for a debilitating condition.
Neuman, Ariel
core  

Clinical heterogeneity associated with KCNA1 mutations include cataplexy and nonataxic presentations [PDF]

open access: yes, 2015
Mutations in the KCNA1 gene are known to cause episodic ataxia/myokymia syndrome type 1 (EA1). Here, we describe two families with unique presentations who were enrolled in an IRB-approved study, extensively phenotyped, and whole exome sequencing (WES ...
Agrawal, Pankaj B.   +11 more
core   +1 more source

Prolonged Detection of GHB Intake in Urine: Are We Finally There?

open access: yesDrug Testing and Analysis, Volume 17, Issue 12, Page 2429-2446, December 2025.
In a randomised placebo‐controlled trial with 30 volunteers, urinary LC‐MS/MS analysis demonstrated that a tentative GHB‐pentose conjugate remained elevated in urine up to 72 h post‐administration. This biomarker showed clear distinction from placebo and may offer extended detection compared to GHB itself, representing a significant step forward in ...
Kathrine B. Faldborg   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy